JPH0469610B2 - - Google Patents
Info
- Publication number
- JPH0469610B2 JPH0469610B2 JP60103807A JP10380785A JPH0469610B2 JP H0469610 B2 JPH0469610 B2 JP H0469610B2 JP 60103807 A JP60103807 A JP 60103807A JP 10380785 A JP10380785 A JP 10380785A JP H0469610 B2 JPH0469610 B2 JP H0469610B2
- Authority
- JP
- Japan
- Prior art keywords
- interleukin
- present
- inducer
- weight
- cells
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 102000000588 Interleukin-2 Human genes 0.000 claims description 38
- 108010002350 Interleukin-2 Proteins 0.000 claims description 38
- 239000000411 inducer Substances 0.000 claims description 21
- 210000004027 cell Anatomy 0.000 description 7
- 230000001419 dependent effect Effects 0.000 description 6
- 241000411851 herbal medicine Species 0.000 description 6
- 239000000203 mixture Substances 0.000 description 6
- 239000000843 powder Substances 0.000 description 6
- 230000001939 inductive effect Effects 0.000 description 5
- 229940104230 thymidine Drugs 0.000 description 5
- 241000202807 Glycyrrhiza Species 0.000 description 4
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 description 4
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 description 4
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 description 4
- 229940010454 licorice Drugs 0.000 description 4
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 4
- 210000005087 mononuclear cell Anatomy 0.000 description 4
- 239000006228 supernatant Substances 0.000 description 4
- 208000024891 symptom Diseases 0.000 description 4
- 244000000626 Daucus carota Species 0.000 description 3
- 235000002767 Daucus carota Nutrition 0.000 description 3
- 244000273928 Zingiber officinale Species 0.000 description 3
- 235000006886 Zingiber officinale Nutrition 0.000 description 3
- 239000002775 capsule Substances 0.000 description 3
- 239000006285 cell suspension Substances 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 238000009472 formulation Methods 0.000 description 3
- 235000008397 ginger Nutrition 0.000 description 3
- 239000008187 granular material Substances 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- 102000008072 Lymphokines Human genes 0.000 description 2
- 108010074338 Lymphokines Proteins 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- 210000001744 T-lymphocyte Anatomy 0.000 description 2
- IQFYYKKMVGJFEH-XLPZGREQSA-N Thymidine Natural products O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](CO)[C@@H](O)C1 IQFYYKKMVGJFEH-XLPZGREQSA-N 0.000 description 2
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 2
- 238000011047 acute toxicity test Methods 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 230000001965 increasing effect Effects 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 231100000053 low toxicity Toxicity 0.000 description 2
- 235000019359 magnesium stearate Nutrition 0.000 description 2
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 238000010600 3H thymidine incorporation assay Methods 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- DWRXFEITVBNRMK-UHFFFAOYSA-N Beta-D-1-Arabinofuranosylthymine Natural products O=C1NC(=O)C(C)=CN1C1C(O)C(O)C(CO)O1 DWRXFEITVBNRMK-UHFFFAOYSA-N 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- 108010062580 Concanavalin A Proteins 0.000 description 1
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 1
- 208000029462 Immunodeficiency disease Diseases 0.000 description 1
- 102000008070 Interferon-gamma Human genes 0.000 description 1
- 108010074328 Interferon-gamma Proteins 0.000 description 1
- 102000015696 Interleukins Human genes 0.000 description 1
- 108010063738 Interleukins Proteins 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 1
- 244000131316 Panax pseudoginseng Species 0.000 description 1
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
- 244000088415 Raphanus sativus Species 0.000 description 1
- 235000005733 Raphanus sativus var niger Nutrition 0.000 description 1
- 235000006140 Raphanus sativus var sativus Nutrition 0.000 description 1
- 244000155437 Raphanus sativus var. niger Species 0.000 description 1
- 230000006052 T cell proliferation Effects 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- IQFYYKKMVGJFEH-UHFFFAOYSA-N beta-L-thymidine Natural products O=C1NC(=O)C(C)=CN1C1OC(CO)C(O)C1 IQFYYKKMVGJFEH-UHFFFAOYSA-N 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 231100000517 death Toxicity 0.000 description 1
- 239000012091 fetal bovine serum Substances 0.000 description 1
- 210000000245 forearm Anatomy 0.000 description 1
- 229940044627 gamma-interferon Drugs 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 235000008434 ginseng Nutrition 0.000 description 1
- 239000007902 hard capsule Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 229960002897 heparin Drugs 0.000 description 1
- 229920000669 heparin Polymers 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 230000004073 interleukin-2 production Effects 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 1
- 239000008108 microcrystalline cellulose Substances 0.000 description 1
- 229940016286 microcrystalline cellulose Drugs 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 229940049954 penicillin Drugs 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 210000004989 spleen cell Anatomy 0.000 description 1
- 229960005322 streptomycin Drugs 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
Landscapes
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Plant Substances (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP60103807A JPS61263923A (ja) | 1985-05-17 | 1985-05-17 | インタ−ロイキン−２誘起剤 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP60103807A JPS61263923A (ja) | 1985-05-17 | 1985-05-17 | インタ−ロイキン−２誘起剤 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS61263923A JPS61263923A (ja) | 1986-11-21 |
| JPH0469610B2 true JPH0469610B2 (enrdf_load_stackoverflow) | 1992-11-06 |
Family
ID=14363670
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP60103807A Granted JPS61263923A (ja) | 1985-05-17 | 1985-05-17 | インタ−ロイキン−２誘起剤 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS61263923A (enrdf_load_stackoverflow) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0645550B2 (ja) * | 1990-06-27 | 1994-06-15 | 新也 大久保 | 抗癌剤 |
| CN1055022C (zh) * | 1997-03-03 | 2000-08-02 | 中国预防医学科学院生物技术新药研究中心 | 复方干扰素抗病毒合剂及其制作技术和用途 |
-
1985
- 1985-05-17 JP JP60103807A patent/JPS61263923A/ja active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| JPS61263923A (ja) | 1986-11-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103768534B (zh) | 一种具有抗肿瘤活性的中药组合物 | |
| JPS5936619A (ja) | 制癌補助剤 | |
| CN102626468B (zh) | 一种治疗乙肝的中药组合物及其制备方法和应用 | |
| CN115337348B (zh) | 一种治疗热结血脉的中药组合物 | |
| CN115337347B (zh) | 一种中药组合物在制备治疗冠心病的药物中的应用 | |
| CN102657736B (zh) | 一种治疗类风湿性关节炎的药物组合物及其制备方法 | |
| WO1993013787A1 (en) | Immunopotentiating agent | |
| CN117731680A (zh) | 一种用于小儿腹泻的药物组合物及其制备方法和应用 | |
| CN115227757B (zh) | 一种中药组合物在制备降压药物中的应用 | |
| JPH0469610B2 (enrdf_load_stackoverflow) | ||
| CN105031468A (zh) | 具有治疗慢性肾脏病作用的益智仁提取物及其应用 | |
| CN104706881A (zh) | 一种具有调节睡眠功能的保健品 | |
| CN104825922B (zh) | 具有抗结直肠癌活性的中药组合物及其制备方法和应用 | |
| CN103599265B (zh) | 一种辐射防护复方中药 | |
| CN100428942C (zh) | 一种养心安神药物及其制备方法 | |
| JPH01246224A (ja) | 抗痴呆症剤 | |
| CN109078055B (zh) | 异阿魏酸、含异阿魏酸中药提取物及升麻的用途 | |
| CN101502536B (zh) | 香柏总黄酮及其制备方法与医药用途 | |
| CN103919819A (zh) | 一种茯苓天然组合物及其抗癌止呕的用途 | |
| CN104666927A (zh) | 一种中药组合物及其调节人体免疫功能和/或抗肿瘤应用 | |
| JPH0643327B2 (ja) | 免疫賦活剤 | |
| JPH0643326B2 (ja) | 免疫賦活剤 | |
| JPH0469619B2 (enrdf_load_stackoverflow) | ||
| JPS61112026A (ja) | 制癌剤 | |
| CN104825784B (zh) | 一种具有抗胃癌活性的中药组合物及其制备方法和应用 |